sellWeak cluster of 2
Steve Forte sold $7,848 of RPTX
EVP, CHIEF FINANCIAL OFFICER at Repare Therapeutics Inc.. 6,884 shares at an average of $1.14, traded Mar 12, 2025, filed Mar 14, 2025.
Warning score
35Value
$7,848
6,884 shares
Holdings after
54,786
-11% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +22RoleCFO
- 0Trade size$8k at market
- +5Share of holdings soldSold 11% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-25-008106, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 12, 2025 | SOpen-market sale Common Shares | -6,884 | $1.14 | $7,848 | 54,786 | Mar 14, 2025 |
Related signals
Other insiders at Repare Therapeutics Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | Repare Therapeutics Inc. | Maria Koehler EVP, CHIEF MEDICAL OFFICER | $4,099 3,596 shares | -2% | |
| 17Weak | Repare Therapeutics Inc. | Steve Forte EVP, CHIEF FINANCIAL OFFICER | $12k 2,475 shares | -6% | |
| 10Weak | Repare Therapeutics Inc. | Maria Koehler EVP, CHIEF MEDICAL OFFICER | $7,000 1,500 shares | -1% | |
| 26Weak | Repare Therapeutics Inc. | Lloyd Mitchell Segal PRESIDENT AND CEO | $37k 7,950 shares | -9% | |
| 10Weak | Repare Therapeutics Inc. | Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER | $6,305 1,350 shares | -2% | |
| 43Moderate | RPTXbuy Repare Therapeutics Inc. | Bvf Partners L P/il owner | $6.2M 1,227,301 shares | +26% | |
| 35Weak | RPTXbuy Repare Therapeutics Inc. | Bvf Partners L P/il owner | $2.8M 783,709 shares | +18% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.